(Q42601651)

3 November 2017

Bioavailability and analgesic effect of sustained release cetobemidone capsules in cancer patients with chronic pain of malignant origin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358136

17 September 2022

0 references

1 reference

M. Kjaer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358136

17 September 2022

H. Nielsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358136

17 September 2022

F. E. Olsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358136

17 September 2022

L. S. Andersen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358136

17 September 2022

J. Philipsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358136

17 September 2022

G. Velander

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358136

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1358136

17 September 2022

publication date

1 January 1992

1 reference

3 November 2017

1 reference

3 November 2017

31

1 reference

3 November 2017

577-583

1 reference

3 November 2017

5

1 reference

High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment

3 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

Controlled-release morphine (MST Contin) in advanced cancer. The European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

Clinical pharmacokinetics and oral bioavailability of ketobemidone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

A comparative study of intramuscular buprenorphine and morphine in the treatment of chronic pain of malignant origin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

The analgesic effect of the GABA-agonist THIP in patients with chronic pain of malignant origin. A phase-1-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

Controlled release morphine tablets: a double-blind trial in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088310

10.3109/02841869209088310

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference